世界のDNA・RNAオリゴヌクレオチド市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global DNA & RNA Oligonucleotides Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A14966 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、DNA・RNAオリゴヌクレオチドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。DNA・RNAオリゴヌクレオチドの種類別市場規模（DNAオリゴヌクレオチド、RNAオリゴヌクレオチド）、用途別市場規模（病院・クリニック、バイオ医薬品企業、学術・研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・DNA・RNAオリゴヌクレオチドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Eurofins Scientific、Natera、BGI、Illumina、Roche、LabCorp、Berry Genomics、Brooks Life Sciences、Macrogen、Genotypic Technology、Dna Link ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：DNAオリゴヌクレオチド、RNAオリゴヌクレオチド ・用途別分析2016年-2026年：病院・クリニック、バイオ医薬品企業、学術・研究機関、その他 ・DNA・RNAオリゴヌクレオチドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・DNA・RNAオリゴヌクレオチドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・DNA・RNAオリゴヌクレオチドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・DNA・RNAオリゴヌクレオチドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・DNA・RNAオリゴヌクレオチドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The DNA & RNA Oligonucleotides market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global DNA & RNA Oligonucleotides size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global DNA & RNA Oligonucleotides market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
DNA & RNA Oligonucleotides market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
DNA Oligonucleotides
RNA Oligonucleotides

Market segment by Application, can be divided into
Hospitals and Clinics
Biopharma Companies
Academic & Research Organizations
Others

Market segment by players, this report covers
Eurofins Scientific
Natera
BGI
Illumina
Roche
LabCorp
Berry Genomics
Brooks Life Sciences
Macrogen
Genotypic Technology
Dna Link

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe DNA & RNA Oligonucleotides product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of DNA & RNA Oligonucleotides, with revenue, gross margin and global market share of DNA & RNA Oligonucleotides from 2019 to 2021.
Chapter 3, the DNA & RNA Oligonucleotides competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and DNA & RNA Oligonucleotides market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe DNA & RNA Oligonucleotides research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of DNA & RNA Oligonucleotides
1.2 Classification of DNA & RNA Oligonucleotides by Type
1.2.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Type in 2020
1.2.3 DNA Oligonucleotides
1.2.4 RNA Oligonucleotides
1.3 Global DNA & RNA Oligonucleotides Market by Application
1.3.1 Overview: Global DNA & RNA Oligonucleotides Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals and Clinics
1.3.3 Biopharma Companies
1.3.4 Academic & Research Organizations
1.3.5 Others
1.4 Global DNA & RNA Oligonucleotides Market Size & Forecast
1.5 Global DNA & RNA Oligonucleotides Market Size and Forecast by Region
1.5.1 Global DNA & RNA Oligonucleotides Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global DNA & RNA Oligonucleotides Market Size by Region, (2016-2021)
1.5.3 North America DNA & RNA Oligonucleotides Market Size and Prospect (2016-2026)
1.5.4 Europe DNA & RNA Oligonucleotides Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific DNA & RNA Oligonucleotides Market Size and Prospect (2016-2026)
1.5.6 South America DNA & RNA Oligonucleotides Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa DNA & RNA Oligonucleotides Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 DNA & RNA Oligonucleotides Market Drivers
1.6.2 DNA & RNA Oligonucleotides Market Restraints
1.6.3 DNA & RNA Oligonucleotides Trends Analysis
2 Company Profiles
2.1 Eurofins Scientific
2.1.1 Eurofins Scientific Details
2.1.2 Eurofins Scientific Major Business
2.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
2.1.4 Eurofins Scientific DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Eurofins Scientific Recent Developments and Future Plans
2.2 Natera
2.2.1 Natera Details
2.2.2 Natera Major Business
2.2.3 Natera DNA & RNA Oligonucleotides Product and Solutions
2.2.4 Natera DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Natera Recent Developments and Future Plans
2.3 BGI
2.3.1 BGI Details
2.3.2 BGI Major Business
2.3.3 BGI DNA & RNA Oligonucleotides Product and Solutions
2.3.4 BGI DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BGI Recent Developments and Future Plans
2.4 Illumina
2.4.1 Illumina Details
2.4.2 Illumina Major Business
2.4.3 Illumina DNA & RNA Oligonucleotides Product and Solutions
2.4.4 Illumina DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Illumina Recent Developments and Future Plans
2.5 Roche
2.5.1 Roche Details
2.5.2 Roche Major Business
2.5.3 Roche DNA & RNA Oligonucleotides Product and Solutions
2.5.4 Roche DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Roche Recent Developments and Future Plans
2.6 LabCorp
2.6.1 LabCorp Details
2.6.2 LabCorp Major Business
2.6.3 LabCorp DNA & RNA Oligonucleotides Product and Solutions
2.6.4 LabCorp DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 LabCorp Recent Developments and Future Plans
2.7 Berry Genomics
2.7.1 Berry Genomics Details
2.7.2 Berry Genomics Major Business
2.7.3 Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
2.7.4 Berry Genomics DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Berry Genomics Recent Developments and Future Plans
2.8 Brooks Life Sciences
2.8.1 Brooks Life Sciences Details
2.8.2 Brooks Life Sciences Major Business
2.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
2.8.4 Brooks Life Sciences DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Brooks Life Sciences Recent Developments and Future Plans
2.9 Macrogen
2.9.1 Macrogen Details
2.9.2 Macrogen Major Business
2.9.3 Macrogen DNA & RNA Oligonucleotides Product and Solutions
2.9.4 Macrogen DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Macrogen Recent Developments and Future Plans
2.10 Genotypic Technology
2.10.1 Genotypic Technology Details
2.10.2 Genotypic Technology Major Business
2.10.3 Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
2.10.4 Genotypic Technology DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Genotypic Technology Recent Developments and Future Plans
2.11 Dna Link
2.11.1 Dna Link Details
2.11.2 Dna Link Major Business
2.11.3 Dna Link DNA & RNA Oligonucleotides Product and Solutions
2.11.4 Dna Link DNA & RNA Oligonucleotides Revenue, Gross Margin and Market Share (2019-2021)
2.11.5 Dna Link Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global DNA & RNA Oligonucleotides Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 DNA & RNA Oligonucleotides Players Market Share
3.2.2 Top 10 DNA & RNA Oligonucleotides Players Market Share
3.2.3 Market Competition Trend
3.3 DNA & RNA Oligonucleotides Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global DNA & RNA Oligonucleotides Revenue and Market Share by Type (2016-2021)
4.2 Global DNA & RNA Oligonucleotides Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2016-2021)
5.2 DNA & RNA Oligonucleotides Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America DNA & RNA Oligonucleotides Revenue by Type (2016-2026)
6.2 North America DNA & RNA Oligonucleotides Revenue by Application (2016-2026)
6.3 North America DNA & RNA Oligonucleotides Market Size by Country
6.3.1 North America DNA & RNA Oligonucleotides Revenue by Country (2016-2026)
6.3.2 United States DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
6.3.3 Canada DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
6.3.4 Mexico DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe DNA & RNA Oligonucleotides Revenue by Type (2016-2026)
7.2 Europe DNA & RNA Oligonucleotides Revenue by Application (2016-2026)
7.3 Europe DNA & RNA Oligonucleotides Market Size by Country
7.3.1 Europe DNA & RNA Oligonucleotides Revenue by Country (2016-2026)
7.3.2 Germany DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
7.3.3 France DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
7.3.4 United Kingdom DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
7.3.5 Russia DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
7.3.6 Italy DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific DNA & RNA Oligonucleotides Revenue by Type (2016-2026)
8.2 Asia-Pacific DNA & RNA Oligonucleotides Revenue by Application (2016-2026)
8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region
8.3.1 Asia-Pacific DNA & RNA Oligonucleotides Revenue by Region (2016-2026)
8.3.2 China DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8.3.3 Japan DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8.3.4 South Korea DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8.3.5 India DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
8.3.7 Australia DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America DNA & RNA Oligonucleotides Revenue by Type (2016-2026)
9.2 South America DNA & RNA Oligonucleotides Revenue by Application (2016-2026)
9.3 South America DNA & RNA Oligonucleotides Market Size by Country
9.3.1 South America DNA & RNA Oligonucleotides Revenue by Country (2016-2026)
9.3.2 Brazil DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
9.3.3 Argentina DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa DNA & RNA Oligonucleotides Revenue by Type (2016-2026)
10.2 Middle East & Africa DNA & RNA Oligonucleotides Revenue by Application (2016-2026)
10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country
10.3.1 Middle East & Africa DNA & RNA Oligonucleotides Revenue by Country (2016-2026)
10.3.2 Turkey DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
10.3.4 UAE DNA & RNA Oligonucleotides Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global DNA & RNA Oligonucleotides Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global DNA & RNA Oligonucleotides Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market DNA & RNA Oligonucleotides Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global DNA & RNA Oligonucleotides Revenue (USD Million) by Region (2016-2021)
Table 5. Global DNA & RNA Oligonucleotides Revenue Market Share by Region (2021-2026)
Table 6. Eurofins Scientific Corporate Information, Head Office, and Major Competitors
Table 7. Eurofins Scientific Major Business
Table 8. Eurofins Scientific DNA & RNA Oligonucleotides Product and Solutions
Table 9. Eurofins Scientific DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Natera Corporate Information, Head Office, and Major Competitors
Table 11. Natera Major Business
Table 12. Natera DNA & RNA Oligonucleotides Product and Solutions
Table 13. Natera DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BGI Corporate Information, Head Office, and Major Competitors
Table 15. BGI Major Business
Table 16. BGI DNA & RNA Oligonucleotides Product and Solutions
Table 17. BGI DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Illumina Corporate Information, Head Office, and Major Competitors
Table 19. Illumina Major Business
Table 20. Illumina DNA & RNA Oligonucleotides Product and Solutions
Table 21. Illumina DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Roche Corporate Information, Head Office, and Major Competitors
Table 23. Roche Major Business
Table 24. Roche DNA & RNA Oligonucleotides Product and Solutions
Table 25. Roche DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. LabCorp Corporate Information, Head Office, and Major Competitors
Table 27. LabCorp Major Business
Table 28. LabCorp DNA & RNA Oligonucleotides Product and Solutions
Table 29. LabCorp DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Berry Genomics Corporate Information, Head Office, and Major Competitors
Table 31. Berry Genomics Major Business
Table 32. Berry Genomics DNA & RNA Oligonucleotides Product and Solutions
Table 33. Berry Genomics DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Brooks Life Sciences Corporate Information, Head Office, and Major Competitors
Table 35. Brooks Life Sciences Major Business
Table 36. Brooks Life Sciences DNA & RNA Oligonucleotides Product and Solutions
Table 37. Brooks Life Sciences DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Macrogen Corporate Information, Head Office, and Major Competitors
Table 39. Macrogen Major Business
Table 40. Macrogen DNA & RNA Oligonucleotides Product and Solutions
Table 41. Macrogen DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Genotypic Technology Corporate Information, Head Office, and Major Competitors
Table 43. Genotypic Technology Major Business
Table 44. Genotypic Technology DNA & RNA Oligonucleotides Product and Solutions
Table 45. Genotypic Technology DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Dna Link Corporate Information, Head Office, and Major Competitors
Table 47. Dna Link Major Business
Table 48. Dna Link DNA & RNA Oligonucleotides Product and Solutions
Table 49. Dna Link DNA & RNA Oligonucleotides Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 50. Global DNA & RNA Oligonucleotides Revenue (USD Million) by Players (2019-2021)
Table 51. Global DNA & RNA Oligonucleotides Revenue Share by Players (2019-2021)
Table 52. Breakdown of DNA & RNA Oligonucleotides by Company Type (Tier 1, Tier 2 and Tier 3)
Table 53. DNA & RNA Oligonucleotides Players Head Office, Products and Services Provided
Table 54. DNA & RNA Oligonucleotides Mergers & Acquisitions in the Past Five Years
Table 55. DNA & RNA Oligonucleotides New Entrants and Expansion Plans
Table 56. Global DNA & RNA Oligonucleotides Revenue (USD Million) by Type (2016-2021)
Table 57. Global DNA & RNA Oligonucleotides Revenue Share by Type (2016-2021)
Table 58. Global DNA & RNA Oligonucleotides Revenue Forecast by Type (2021-2026)
Table 59. Global DNA & RNA Oligonucleotides Revenue by Application (2016-2021)
Table 60. Global DNA & RNA Oligonucleotides Revenue Forecast by Application (2021-2026)
Table 61. North America DNA & RNA Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 62. North America DNA & RNA Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 63. North America DNA & RNA Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 64. North America DNA & RNA Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 65. North America DNA & RNA Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 66. North America DNA & RNA Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 67. Europe DNA & RNA Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 68. Europe DNA & RNA Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 69. Europe DNA & RNA Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 70. Europe DNA & RNA Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 71. Europe DNA & RNA Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 72. Europe DNA & RNA Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 73. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 74. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 75. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 76. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 77. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Region (2016-2021) & (USD Million)
Table 78. Asia-Pacific DNA & RNA Oligonucleotides Revenue by Region (2021-2026) & (USD Million)
Table 79. South America DNA & RNA Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 80. South America DNA & RNA Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 81. South America DNA & RNA Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 82. South America DNA & RNA Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 83. South America DNA & RNA Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 84. South America DNA & RNA Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
Table 85. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Type (2016-2021) & (USD Million)
Table 86. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Type (2021-2026) & (USD Million)
Table 87. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Application (2016-2021) & (USD Million)
Table 88. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Application (2021-2026) & (USD Million)
Table 89. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Country (2016-2021) & (USD Million)
Table 90. Middle East & Africa DNA & RNA Oligonucleotides Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. DNA & RNA Oligonucleotides Picture
Figure 2. Global DNA & RNA Oligonucleotides Revenue Market Share by Type in 2020
Figure 3. DNA Oligonucleotides
Figure 4. RNA Oligonucleotides
Figure 5. DNA & RNA Oligonucleotides Revenue Market Share by Application in 2020
Figure 6. Hospitals and Clinics Picture
Figure 7. Biopharma Companies Picture
Figure 8. Academic & Research Organizations Picture
Figure 9. Others Picture
Figure 10. Global DNA & RNA Oligonucleotides Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global DNA & RNA Oligonucleotides Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global DNA & RNA Oligonucleotides Revenue Market Share by Region (2016-2026)
Figure 13. Global DNA & RNA Oligonucleotides Revenue Market Share by Region in 2020
Figure 14. North America DNA & RNA Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe DNA & RNA Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific DNA & RNA Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America DNA & RNA Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa DNA & RNA Oligonucleotides Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. DNA & RNA Oligonucleotides Market Drivers
Figure 20. DNA & RNA Oligonucleotides Market Restraints
Figure 21. DNA & RNA Oligonucleotides Market Trends
Figure 22. Eurofins Scientific Recent Developments and Future Plans
Figure 23. Natera Recent Developments and Future Plans
Figure 24. BGI Recent Developments and Future Plans
Figure 25. Illumina Recent Developments and Future Plans
Figure 26. Roche Recent Developments and Future Plans
Figure 27. LabCorp Recent Developments and Future Plans
Figure 28. Berry Genomics Recent Developments and Future Plans
Figure 29. Brooks Life Sciences Recent Developments and Future Plans
Figure 30. Macrogen Recent Developments and Future Plans
Figure 31. Genotypic Technology Recent Developments and Future Plans
Figure 32. Dna Link Recent Developments and Future Plans
Figure 33. Global DNA & RNA Oligonucleotides Revenue Share by Players in 2020
Figure 34. DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players DNA & RNA Oligonucleotides Revenue Market Share in 2020
Figure 36. Global Top 10 Players DNA & RNA Oligonucleotides Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global DNA & RNA Oligonucleotides Revenue Share by Type in 2020
Figure 39. Global DNA & RNA Oligonucleotides Market Share Forecast by Type (2021-2026)
Figure 40. Global DNA & RNA Oligonucleotides Revenue Share by Application in 2020
Figure 41. Global DNA & RNA Oligonucleotides Market Share Forecast by Application (2021-2026)
Figure 42. North America DNA & RNA Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 43. North America DNA & RNA Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 44. North America DNA & RNA Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 45. United States DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe DNA & RNA Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 49. Europe DNA & RNA Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 50. Europe DNA & RNA Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 51. Germany DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific DNA & RNA Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific DNA & RNA Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific DNA & RNA Oligonucleotides Revenue Market Share by Region (2016-2026)
Figure 59. China DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America DNA & RNA Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 66. South America DNA & RNA Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 67. South America DNA & RNA Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 68. Brazil DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa DNA & RNA Oligonucleotides Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa DNA & RNA Oligonucleotides Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa DNA & RNA Oligonucleotides Revenue Market Share by Country (2016-2026)
Figure 73. Turkey DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE DNA & RNA Oligonucleotides Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---